Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteers.

Authors
Type
Published Article
Journal
Journal of Antimicrobial Chemotherapy
1460-2091
Publisher
Oxford University Press
Publication Date
Volume
66
Issue
3
Pages
635–640
Identifiers
DOI: 10.1093/jac/dkq468
PMID: 21172791
Source
Medline
License
Unknown

Abstract

These pharmacokinetic data show that therapeutic plasma concentrations of lopinavir can be achieved with 200/150 mg of lopinavir/ritonavir twice daily (one Meltrex tablet and one 100 mg ritonavir capsule twice daily).

Statistics

Seen <100 times